Ameriprise Initiates Cigna at Buy
Medicare to Adjust Disputed Star Rating Measure: Bloomberg News
10 Health Care Stocks Whale Activity In Today's Session
Returns On Capital At Cigna Group (NYSE:CI) Have Hit The Brakes
Morgan Stanley Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $403
Wells Fargo Maintains Cigna Group(CI.US) With Hold Rating, Maintains Target Price $355
The cigna group clarifies that it will not seek to merge with Humana in the future and will actively repurchase stocks.
Gelonghui November 12th | The Cigna Group stated on Monday that it will not seek to merge with its competitor Humana, and is still focused on an acquisition that is 'strategically consistent, financially attractive, and likely to be completed'. Earlier reports suggested that Cigna had restarted plans to merge with Humana, with both parties having terminated acquisition negotiations last year due to failure to reach a price agreement. Cigna also stated that it is expected to actively repurchase stocks in the fourth quarter and in 2025, and will announce this news before meeting with investors and analysts in the coming weeks. Analysts point out that after the U.S. presidential election, Humana's stock price rose as investors bet on President Trump.
Dow Ends Session on Top While S&P and Nasdaq Inch up With CPI Data Looming
US Equity Market Mixed as Nasdaq Takes Breather While S&P 500, Dow Touch New Record Highs
Cigna (NYSE:CI) Surges, Not Buying Humana
Top Midday Stories: Cigna Won't Pursue Combination With Humana; AbbVie Phase 2 Schizophrenia Drug Trials Fail to Meet Primary Endpoints
U.S. stocks are unusual|The cigna group rose by 7.5%, giving up the merger with humana and continuing to actively buy back stocks
The Cigna Group, a giant in the American medical insurance business, is now up 7.5% at $343.74 on November 11th. In terms of news, the company's merger talks with Humana have once again fallen through. Cigna announced that it will not merge with Humana, emphasizing in a statement that the company will continue to adhere to its established M&A standards, only considering acquisitions that are strategically significant, financially attractive, and have a high probability of completion. The company also plans to continue actively repurchasing stocks in the fourth quarter and in 2025, using the majority of the proceeds from the sale of its medical insurance business. Currently, the balance of share buyback authorization is $5.3 billion. (Gelonghui)
Cigna Not Pursuing Humana Combination; Affirms 2024 Earnings Outlook
Cigna on Pace for Largest Percent Increase Since December 2023 -- Data Talk
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Sector Update: Health Care Stocks Mixed Premarket Monday
Cigna Won't Do Humana Deal -- WSJ
The cigna group (CI.US) abandons the merger with humana (HUM.US) to focus on share buyback and growth prospects.
Health insurance company the cigna group's merger negotiations with humana have once again collapsed, the cigna group announced that it will not merge with humana.
Cigna Group Confirms It Isn't Looking to Acquire Humana
Express News | Cigna Shares Extend Gains, Last up 9.5% Premarket